Skip to main content
. Author manuscript; available in PMC: 2012 Apr 30.
Published in final edited form as: Hypertens Pregnancy. 2010;29(4):399–409. doi: 10.3109/10641950903214633

Table 2.

Baseline CRP concentration and change in CRP are not associated with recurrence of preeclampsia

Preeclampsia (n=50) Controls (n=205)
Median (range) Median (range) OR (95% CI) ## Adjusted OR (95% CI) ##
Baseline CRP (mg/dL) 1.17 (0.09, 5.72) 1.01 (0.01, 4.97) 1.000 (1.000, 1.000) 1.0 (1.000, 1.000)*
CRP closest to delivery (mg/dL) 0.71 (0.06, 2.94) 0.76 (0.01, 4.62)
Change in CRP (mg/dL) −0.02 (−0.22, 0.30) −0.02 (−0.43, 0.05) 0.996 (0.992, 1.001) 0.993 (0.986, 1.000)#
*

Controlling for BMI, gestational age at baseline sample collection, race, age, and smoking status.

#

Controlling for BMI, gestational age at baseline sample collection, race, age, smoking status, baseline CRP concentration and aspirin treatment.

##

Odds ratio represents an increase in odds for each μg/dl increase in CRP.